Precision PromiseSM Clinical Trial Consortium Sites

Home Research Precision PromiseSM Precision PromiseSM Clinical Trial Consortium Sites

Precision PromiseSM Clinical Trial Consortium Sites

Precision Promise will launch across Clinical Trial Consortium sites that have been selected throughout the country.

Cedars-Sinai Medical Center (Los Angeles, CA)
Principal investigator: Andrew Hendifar, MD

Dana Farber/Harvard Cancer Center (Boston, MA)
Principal investigator: Brian Wolpin, MD, MPH

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance/University of Washington (Seattle, WA)
Principal investigator: Sunil Hingorani, MD, PhD

Johns Hopkins (Baltimore, MD)
Principal Investigator: Daniel Laheru, MD

MD Anderson (Houston, TX)
Principal Investigator: Milind Javle, MD

Memorial Sloan Kettering Cancer Center (New York, NY)
Principal investigator: Eileen O’Reilly, MD

Perlmutter Cancer Center/NYU Langone Health (New York, NY)
Principal investigator: Diane Simeone, MD

University of California, San Diego (San Diego, CA)
Principal investigator: Andrew Lowy, MD

University of California, San Francisco (San Francisco, CA)
Principal investigator: Andrew Ko, MD

University of Chicago (Chicago, IL)
Principal investigator: Hedy Kindler, MD

University of Florida (Gainesville, FL)
Principal investigator: Thomas George, MD, FACP

University of Pennsylvania (Philadelphia, PA)
Principal investigator: Gregory Beatty, MD, PhD

Virginia Mason Medical Center (Seattle, WA)
Principal investigator: Vincent Picozzi, MD

Washington University (St. Louis, MO)
Principal investigator: Andrea Wang-Gillam, MD, PhD

Other Relevant Topics:


Precision Promise Latest News

PRECISION PROMISESM is a service mark of Pancreatic Cancer Action Network, Inc.

Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.

shop purple logo

Gear, apparel, accessories and more to show off your purple pride.

Shop Now 

©2019 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy

Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.

The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.